Labcorp支持Cellens开发针对膀胱癌的物理检测技术。
Labcorp backs Cellens in developing physics test aimed at bladder cancer
生物技术与制药领域的最新动态
Labcorp backs Cellens in developing physics test aimed at bladder cancer
Notice of email fulfilment change
Voya Investment Management LLC Cuts Stake in Agilent Technologies, Inc. $A - MarketBeat
Spatial Transcriptomics Market Size, Trends & Growth Report by 2034 - Straits Research
Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsy
Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 - Insider Monkey
Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 - Yahoo Finance
Shanghai Xianxiang Medical Technology divulges new EGFR degradation inducers
Laekna Pharmaceutical describes new WRN inhibitors
New NLRP3 inhibitors disclosed in Neushen Therapeutics patent
Shandong Simcere Medgenn Bio-Pharmaceutical discovers new CDK4/cyclin D1 inhibitors
Miracle babies, antibiotic improv and T-cell tamers: Fierce's favorite research stories of 2025
Updated: Pfizer discloses patient death in Hympavzi hemophilia trial
Will Agilent’s (A) Native-Read Sequencing Push with Wasatch BioLabs Redefine Its Genomics Narrative? - simplywall.st
Will Agilent’s (A) Native-Read Sequencing Push with Wasatch BioLabs Redefine Its Genomics Narrative? - simplywall.st
Biopharma CEO optimism is wavering in the US
Barclays turns more bullish on 10x Genomics, Inc. (TXG) despite uneven research spending - MSN
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Insider Monkey
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Insider Monkey
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance